141 – What’s Hot in Retina

OD Fee $30

CE Hours = 1

The field of healthcare is moving forward with innovations in both diagnostic and treatment arenas rapidly. Eyecare is in the same revolutionary cycle. As clinicians, we must keep abreast of these changes and understand what is “hot” and applicable and what is “not” and only sounds good in theory. In diagnostics, imaging technologies and artificial intelligence (AI) should be under our radar. In the treatment of various chemotherapeutic agents, new routes of administrations and novel surgical techniques should be scrutinized. This lecture examines a number of these concepts pertaining to posterior segment disease. These include the utilization of AI in both diagnosis and management of various diseases, as well as advances in pharmacogenetic testing, is discussed.